Manufacturing channel feed – Endpoints News

The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Capricor gets Form 483 from FDA; WuXi Biologics' new China factory

3 days ago

Biotech slump forces Resilience to wind down six manufacturing sites, using bankruptcy move

5 days ago

In a break from other biotechs, Twist Bioscience throws support behind tariffs on synthetic DNA

5 days ago

Sanofi leans into 'first-mover advantage' by shipping Beyfortus early, as RSV antibody market set to heat up

6 days ago

Pharma imports into the US return to normal after March tariff stockpiling

Last week

Schott Pharma's €100M+ Hungary expansion; Antheia’s $56M Series C raise

Last week

Agenus quickly exits CDMO business by selling assets to Zydus for $75M upfront

Last week

Q&A: Sandoz CEO Richard Saynor on generic GLP-1s, Trump's industry impact, and Mark Cuban's company

Last week

Large pharma companies spell out reasons why tariffs will harm US investments

3 weeks ago

Sanofi’s vaccine tech transfer in Vietnam; Almac’s £1B+ revenue milestone

3 weeks ago

FDA rejects Stealth's rare disease drug, but offers potential for accelerated approval

3 weeks ago

Novo Nordisk ‘strongly’ urges against pharma tariffs as comments flood in

3 weeks ago

FDA rejects Savara’s rare lung disease drug over limited manufacturing data

3 weeks ago

US warns drugmakers against misrepresenting cost of imported products

4 weeks ago

FDA names acting head of inspections; J&J again advocates for tax policies as alternative to tariffs

4 weeks ago

Meet the ‘first sale’ rule: A customs loophole pharma companies could use to ease tariff impact

4 weeks ago

Samsung Biologics to separate manufacturing and biosimilar businesses

4 weeks ago

FDA announces efforts to facilitate drug importation from Canada

4 weeks ago

Mark Cuban compounder joins Trump's new manufacturing initiative

5 weeks ago

'Go ahead and do it': Top RFK Jr. deputy dares drugmakers that might pull manufacturing over new price pressure

5 weeks ago

AGC Bio secures lentiviral contract; Thermo Fisher to make Cybin asset

Last month

Updated: Merck KGaA continues US tariff surcharge but at a 'decreased' rate

Last month

Sanofi touts $20B investment in US over five years

Last month

Some generics, biosimilar drugmakers say they can withstand tariff impact

Last month

12 3 4 Next page Last page